DK504389A - Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved - Google Patents

Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved

Info

Publication number
DK504389A
DK504389A DK504389A DK504389A DK504389A DK 504389 A DK504389 A DK 504389A DK 504389 A DK504389 A DK 504389A DK 504389 A DK504389 A DK 504389A DK 504389 A DK504389 A DK 504389A
Authority
DK
Denmark
Prior art keywords
zinc
iron
hydroxidgel
preparation
antigen solution
Prior art date
Application number
DK504389A
Other languages
English (en)
Other versions
DK504389D0 (da
DK170224B1 (da
Inventor
Dieter Bernhardt
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK504389D0 publication Critical patent/DK504389D0/da
Publication of DK504389A publication Critical patent/DK504389A/da
Application granted granted Critical
Publication of DK170224B1 publication Critical patent/DK170224B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK504389A 1988-10-12 1989-10-11 Adjuveret antigenopløsning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved DK170224B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3834729A DE3834729A1 (de) 1988-10-12 1988-10-12 Verwendung von zink-oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
DE3834729 1988-10-12

Publications (3)

Publication Number Publication Date
DK504389D0 DK504389D0 (da) 1989-10-11
DK504389A true DK504389A (da) 1990-04-13
DK170224B1 DK170224B1 (da) 1995-07-03

Family

ID=6364944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK504389A DK170224B1 (da) 1988-10-12 1989-10-11 Adjuveret antigenopløsning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved

Country Status (13)

Country Link
US (1) US5252327A (da)
EP (1) EP0363835B1 (da)
JP (1) JP2756321B2 (da)
KR (1) KR0162074B1 (da)
AT (1) ATE90568T1 (da)
AU (1) AU626920B2 (da)
CA (1) CA1333257C (da)
DE (2) DE3834729A1 (da)
DK (1) DK170224B1 (da)
ES (1) ES2058432T3 (da)
FI (1) FI100946B (da)
IE (1) IE63271B1 (da)
PT (1) PT91953B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007315A1 (de) * 1990-03-08 1991-09-12 Behringwerke Ag Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
EP0640348A1 (en) * 1993-07-26 1995-03-01 Akzo Nobel N.V. Oil-based and water-based adjuvant mixture
DE4333376C2 (de) * 1993-09-30 1995-09-07 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie
DE19511276C2 (de) * 1995-03-27 1999-02-18 Immuno Ag Adjuvans auf der Basis kolloidaler Eisenverbindungen
ES2284287T3 (es) * 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
WO2002069985A2 (en) * 2001-03-05 2002-09-12 Forinnova As Immune response potentiation
DE20103715U1 (de) * 2001-03-05 2002-07-25 Nawa-Heilmittel GmbH, 92361 Berngau Medizinisches Präparat zur Förderung des Anwachsens eines Transplantats, insbesondere von transplantierter Haut an einem Transplantationsort
FR2854803B1 (fr) * 2003-05-16 2005-06-24 Aventis Pasteur Composition vaccinale comprenant du phosphate de fer a titre d'adjuvent vaccinal.
CA2530062A1 (en) * 2003-07-11 2005-01-20 Intercell Ag Hcv vaccines
WO2007025332A1 (en) * 2005-08-29 2007-03-08 Dia-B Tech Limited A peptide and zinc ion composition for treating diabetes and enhancing immune function
JP5798356B2 (ja) * 2011-04-06 2015-10-21 一般財団法人化学及血清療法研究所 新規インフルエンザワクチン安定化剤
GB2571925A (en) * 2018-03-08 2019-09-18 Univ Antwerpen Iron-based vaccine adjuvants
KR20260012291A (ko) * 2018-07-12 2026-01-26 더 리젠츠 오브 더 유니버시티 오브 미시간 면역 반응을 조절할 수 있는 금속 함유 제형의 조성물 및 방법
AU2020256646A1 (en) 2019-04-11 2021-12-09 Xiamen Innovax Biotech Co., Ltd. Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant
CN115463211A (zh) * 2022-08-25 2022-12-13 浙江大学 一种Zn基免疫调节佐剂的制备方法及产品和应用
JPWO2025028658A1 (da) * 2023-08-03 2025-02-06

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189340A (en) * 1967-09-13 1970-04-22 American Cyanamid Co Antigen-Adjuvant Composition
US4684625A (en) * 1982-07-08 1987-08-04 Syntex (U.S.A.) Inc. Method for enhancing the anti-infective activity of muramyldipeptide derivatives
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes

Also Published As

Publication number Publication date
FI100946B (fi) 1998-03-31
KR900005986A (ko) 1990-05-07
AU626920B2 (en) 1992-08-13
US5252327A (en) 1993-10-12
IE893283L (en) 1990-04-12
DK504389D0 (da) 1989-10-11
CA1333257C (en) 1994-11-29
DE3834729A1 (de) 1990-04-19
AU4276689A (en) 1990-04-26
EP0363835A1 (de) 1990-04-18
FI894804A0 (fi) 1989-10-10
DK170224B1 (da) 1995-07-03
PT91953A (pt) 1990-04-30
PT91953B (pt) 1995-05-31
ATE90568T1 (de) 1993-07-15
JP2756321B2 (ja) 1998-05-25
DE58904713D1 (de) 1993-07-22
JPH02149530A (ja) 1990-06-08
IE63271B1 (en) 1995-04-05
FI894804L (fi) 1990-04-13
ES2058432T3 (es) 1994-11-01
EP0363835B1 (de) 1993-06-16
KR0162074B1 (ko) 1998-12-01

Similar Documents

Publication Publication Date Title
DK504389D0 (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
FI886051A7 (fi) Reglerventil.
DE3668230D1 (de) Siliziumventil.
DK198388A (da) Hydrofob silica samt fremgangsmaade til fremstilling og anvendelse af denne
GR3006630T3 (da)
DE59001941D1 (de) Magnetventilbatterie.
BR8602204A (pt) Valvula cardiaca
DE3774857D1 (de) Auf-/zu-absperrventil.
NO862775D0 (no) Anordning med ventilfunksjon.
NO881215L (no) Fremgangsmaate for fremstilling av alger med forbedrete biologiske virkninger.
DE69001463D1 (de) Mikroleckregulierventil.
FI872914A7 (fi) Venttiililaite.
EP0329961A3 (en) Use of 2-oxo-pyrrolidine-1-acetamide for the determination of glomerular filtration rate in humans
NO864941D0 (no) Injeksjonsventil.
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
CA2037709A1 (en) Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DE3773696D1 (de) Magnetventilanordnungen.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
FI890568L (fi) Ulkokäyttöisellä venttiilillä varustettu veriviljelylaite
AU585129B2 (en) N-tridecyl-2,6-dimethyl-morpholine fluoboric acid salt
ZA891242B (en) 24r-scymnol,and preparation and use thereof
DE3771468D1 (de) Einsatzventil.
SE8404090L (sv) Raffinerat detoxifierat endotoxin
DE68920643D1 (de) Ventileinrichtung.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK